Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:46 AM EDT
122.50quote price arrow down-1.14 (-0.92%)
Volume
7,241
Close
123.64quote price arrow down-0.68 (-0.55%)
Volume
3,752,484
52 week range
115.61 - 434.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close123.64
  • 52 Week High434.00
  • 52 Week High Date09/27/21
  • 52 Week Low115.61
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap48.368B
  • Shares Out391.20M
  • 10 Day Average Volume5.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.70
  • YTD % Change-51.32

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close123.64
  • 52 Week High434.00
  • 52 Week High Date09/27/21
  • 52 Week Low115.61
  • 52 Week Low Date06/13/22
  • Market Cap48.368B
  • Shares Out391.20M
  • 10 Day Average Volume5.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.70
  • YTD % Change-51.32

RATIOS/PROFITABILITY

  • EPS (TTM)32.80
  • P/E (TTM)3.77
  • Fwd P/E (NTM)7.90
  • EBITDA (TTM)15.945B
  • ROE (TTM)113.86%
  • Revenue (TTM)22.995B
  • Gross Margin (TTM)82.29%
  • Net Margin (TTM)61.12%
  • Debt To Equity (MRQ)4.24%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Pro Picks: Watch all of Tuesday's big stock calls on CNBC
VIDEO6:5106:51
Pro Picks: Watch all of Tuesday's big stock calls on CNBC

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan Ph.D.
Non-Executive Independent Chairman of the Board, Co-Founder
Stephane Bancel
Chief Executive Officer, Director
Stephen Hoge M.D.
President
James Mock
Chief Financial Officer
Juan Andres
Chief Technical Operations and Quality Officer
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
128.35-1.65-1.27%
REGN
Regeneron Pharmaceuticals Inc
697.33+9.07+1.32%
BIIB
Biogen Inc
197.78-2.84-1.42%
ILMN
Illumina Inc
190.38-3.11-1.61%
ALNY
Alnylam Pharmaceuticals Inc
200.78-1.93-0.95%